Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    

 SummaryChartsNewsCalendarCompanyFinancials 
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on OSIRIS THERAPEUTICS, INC.
06/26 Osiris Appoints Linda Palczuk to serve as its President & CEO
06/26 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial..
06/14 OSIRIS ANNOUNCES ELECTRONICALLY AVAI :   Open Surgical Implantation of a Viable ..
05/31 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial..
05/31 OSIRIS THERAPEUTICS : Appoints David White to its Board of Directors
05/19 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
05/18 OSIRIS THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant (form ..
04/14 OSIRIS THERAPEUTICS : Announces Scientific Manuscript Comparing Impact of Preser..
04/13 Osiris Announces Scientific Manuscript Comparing Impact of Preservation Metho..
04/07 MEDIZONE INTERNATIONAL : Expands Board of Directors to Support Executing on the ..
More news
Sector news : Bio Therapeutic Drugs
08/17 FDA expands use of AstraZeneca/Merck ovarian cancer drug
08/15 Three CEOs resign from Trump council over Charlottesville
08/14DJHot Stocks to Watch in the U.S. and Canada
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
08/11DJGILEAD SCIENCES : England's NHS Turns to Clinical Trial to Make Cheaper HIV Drug..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/28 Midday Gainers / Losers
03/28 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
03/21 After Hours Gainers / Losers
03/13 Midday Gainers / Losers
03/13 Trading in Osiris Therapeutics to be suspended tomorrow, formal delisting to ..
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | US68827R1086 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Linda Palczuk President & Chief Executive Officer
Peter A. Friedli Chairman
Frank D. Czworka Chief Operating Officer
Linda L. Chang Chief Financial Officer
Alla Danilkovitch Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
OSIRIS THERAPEUTICS, INC.0.00%210
AMGEN14.42%122 067
CELGENE CORPORATION10.28%99 867
GILEAD SCIENCES0.70%94 170
REGENERON PHARMACEUTICALS27.48%50 145
VERTEX PHARMACEUTICALS101.07%37 346